M

Mustang Bio
D

MBIO

0.20320
USD
-0.00
(-2.26%)
Market Closed
Volume
5,386
EPS
-1
Div Yield
-
P/E
-0
Market Cap
9,708,946
OverviewSignalsIdeasNews
Related Instruments
    A
    ADUS
    -2.080
    (-1.71%)
    119.760 USD
    C
    CODX
    -0.04000
    (-3.64%)
    1.06000 USD
    I
    INO
    -0.54000
    (-11.25%)
    4.26000 USD
    O
    OPK
    0.01500
    (0.92%)
    1.64500 USD
    V
    VBIV
    0
    (0%)
    0.000000 USD
    V
    VXRT
    -0.05030
    (-7.97%)
    0.58050 USD
    More
News

Title: Mustang Bio

Sector: Healthcare
Industry: Biotechnology
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipelineis currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.